Compare STTK & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | MAMA |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.4M | 602.1M |
| IPO Year | 2020 | 2011 |
| Metric | STTK | MAMA |
|---|---|---|
| Price | $5.65 | $12.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | $15.40 | ★ $21.88 |
| AVG Volume (30 Days) | ★ 1.2M | 646.8K |
| Earning Date | 11-09-2026 | 12-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.02 | 44.44 |
| EPS | N/A | ★ 0.10 |
| Revenue | $1,000,000.00 | ★ $95,420,129.00 |
| Revenue This Year | N/A | $30.53 |
| Revenue Next Year | N/A | $12.40 |
| P/E Ratio | ★ N/A | $130.30 |
| Revenue Growth | N/A | ★ 95.54 |
| 52 Week Low | $1.72 | $9.91 |
| 52 Week High | $8.33 | $21.00 |
| Indicator | STTK | MAMA |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 46.21 |
| Support Level | $5.19 | $12.91 |
| Resistance Level | $6.00 | $13.66 |
| Average True Range (ATR) | 0.36 | 0.57 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 43.49 | 60.90 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.